HRASLS3 Inhibitors
HRASLS3 inhibitors encompass a diverse group of compounds devised to modulate the activity or expression of the HRASLS3 protein, either directly or indirectly. These molecules, stemming from a broad chemical background, predominantly act by targeting associated signaling pathways. For instance, Staurosporine, a potent kinase inhibitor, and compounds like LY294002 and Wortmannin, which are PI3K inhibitors, exhibit the capacity to modulate cellular cascades that HRASLS3 might be implicated in.
Furthermore, BAPTA-AM and Cyclosporin A, by targeting calcium signaling, offer indirect routes to manipulate HRASLS3's cellular actions. Other inhibitors like Genistein or AG 490 emphasize the wide-reaching nature of signaling pathways in cells and how HRASLS3 might be involved in multiple cascades.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Broad-spectrum kinase inhibitor that can suppress various signaling cascades potentially linked to HRASLS3's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor that can modulate pathways associated with HRASLS3. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor influencing pathways potentially related to HRASLS3. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
ERK inhibitor affecting MAPK/ERK signaling pathways potentially connected to HRASLS3. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
Calcium chelator that can influence calcium-dependent signaling routes possibly linked with HRASLS3. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Inhibits calcineurin, impacting calcium-dependent signaling that HRASLS3 may be involved in. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Tyrosine kinase inhibitor potentially affecting signaling pathways where HRASLS3 participates. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
JAK2 inhibitor that can modulate pathways possibly connected to HRASLS3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, which can modulate autophagy, a process in which HRASLS3 may play a role. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can impact JNK signaling pathways that may involve HRASLS3. | ||||||